Home/Investors/NYBC Ventures

NYBC Ventures

Biotech Investor · 2 portfolio companies

Portfolio
2
Focus Areas
4
Top Stage
Pre-clinical

Portfolio Companies

CompanyValuation
Thymmune Therapeutics
Vitestro